Heparin and activin-binding determinants in follistatin and FSTL3

Endocrinology

Volumn 146, Issue 1, 2005, Pages 130-136

  Sidis, Yisrael ^a   Schneyer, Alan L ^a   Keutmann, Henry T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; FOLLISTATIN; FOLLISTATIN LIKE 3; FOLLITROPIN; HEPARIN; HORMONE DERIVATIVE; LYSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DRUG ACTIVITY; HORMONE RELEASE; HUMAN; HUMAN CELL; HYPOPHYSIS CELL; MONKEY; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION;

ACTIVINS; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL ASSAY; CELL LINE; CERCOPITHECUS AETHIOPS; CHROMATOGRAPHY, AFFINITY; COS CELLS; FOLLISTATIN; FOLLISTATIN-RELATED PROTEINS; HEPARIN; HUMANS; LYSINE; MOLECULAR SEQUENCE DATA; MUTATION; RATS; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS;

EID: 11144231704     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-1041     Document Type: Article

References (39)

1. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H 1990 Activin-binding protein from rat ovary is follistatin. Science 247:836-838
2. Schneyer AL, Rzucidlo DA, Sluss PM, Crowley WF 1994 Characterization of unique binding kinetics of follistatin and activin or inhibin in serum. Endocrinology 135:667-674
3. deWinter JP, ten Dijke P, de Vries CJM, van Achterberg TAE, Sugino H, de Waele P, Huylebroeck D, Verschueien K, van den Eijnden-van Raaij AJM 1996 Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors. Mol Cell Endocrinol 116:105-114
4. Besecke LM, Guendner MJ, Schneyer AL, Bauer-Dantoin AC, Jameson JL, Weiss J 1996 Gonadotropin-releasing hormone regulates follicle-stimulating hormone-β gene expression through an activin/follistatin autocrine or paracrine loop. Endocrinology 137:3667-3673
5. DePaolo LV 1997 Inhibins, activins and follistatins: the saga continues. Proc Soc Exp Biol Med 214:328-339
6. Welt C, Sidis Y, Keutmann HT, Schneyer AL 2002 Activins, inhibins and follistatins: from endocrinology to signalling - a paradigm for the new millennium. Exp Biol Med 227:724-752
7. Hileman RE, Fromm JR, Weiler JM, Linhardt RJ 1998 Glycosaminoglycan- protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays 20:156-167
8. Ueno N, Ling N, Ying S-Y, Esch F, Shimasaki S, Guillemin R 1987 Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc Natl Acad Sci USA 84:8282-8286
9. Nakamura T, Sugino K, Titani K, Sugino H 1991 Follistatin, an activin-binding protein, associates with heparan sulfate chains of proteoglycans on follicular granulosa cells. J Biol Chem 266:19432-19437
10. Inouye S, Ling N, Shimasaki S 1992 Localization of the heparin-binding site of follistatin. Mol Cell Endocrinol 90:1-6
11. Schneyer AL, Wang QF, Weiss J, Boepple P, Hall J, Khoury R, Taylor A, Pralong F, Sluss P, Crowley WFJ 1997 Follistatin physiology and potential mechanisms of action in the human. In: Vale W, ed. Inhibin, activin and follistatin: regulatory functions in system and cell biology. Kobe, Japan: Serono Symposia USA; 28-38
12. Shimasaki S, Koga M, Esch F, Cooksey K, Mercado M, Koba A, Ueno N, Ying S-Y, Ling N, Guilleman R 1988 Primary structure of the human follistatin precursor and its genomic organization. Proc Natl Acad Sci USA 85:4218-4222
13. Wong P, Hampton B, Szylobryt E, Gallagher AM, Jaye M, Burgess WH 1995 Analysis of putative heparin-binding domains of fibroblast growth factor-1. J Biol Chem 270:25805-25811
14. Proudfoot AEI, Fritchley S, Borlat F, Shaw JP, Vilbois F, Zwahlen C, Trkola A, Marchant D, Clapham PR, Wells TN 2001 The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J Biol Chem 276:10620-10626
15. Innis CA, Hyvonen M 2003 Crystal structures of the heparan sulphate-binding domain of follistatin: insights into ligand binding. J Biol Chem 278:39969-39977
16. Hayette S, Gadoux M, Martel S, Bertrand S, Tigaud I, Magaud J-P, Rimokh R 1998 FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders. Oncogene 16:2949-2954
17. Tsuchida K, Arai KY, Kuramoto Y, Yamakawa N, Hasegawa Y, Sugino H 2000 Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-β family. J Biol Chem 275:40788-40796
18. Schneyer AL, Tortoriello DV, Sidis Y, Keutmann HT, Matsuzaki T, Holmes WE 2001 Follistatin-related protein (FSRP): a new member of the follistatin gene family. Mol Cell Endocrinol 180:33-38
19. Sidis Y, Tortoriello DV, Holmes WE, Pan Y, Keutmann HT, Schneyer AL 2002 Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin. Endocrinology 143:1613-1624
20. Hill JJ, Davies MV, Pearson AA, Wang JH, Hewick RM, Wolfman NM, Qiu Y 2002 The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 277:40735-40741
21. Inouye S, Guo Y, Ling N, Shimasaki S 1991 Site-specific mutagenesis of human follistatin. Biochem Biophys Res Commun 179:352-358
22. Sidis Y, Schneyer AL, Sluss PM, Johnson LN, Keutmann HT 2001 Follistatin: essential role for the N-terminal domain in activin binding and neutralization. J Biol Chem 276:17718-17726
23. Keutmann HT, Sidis Y, Schneyer AL 2004 The role of follistatin domains in follistatin biological action. Mol Endocrinol 18:228-240
24. Sugino K, Kurosawa N, Nakamura T, Takio K, Shimasaki S, Ling N, Titani K, Sugino H 1993 Molecular heterogeneity of follistatin, an activin-binding protein. J Biol Chem 268:15579-15587
25. Sumitomo S, Inouye S, Liu X-J, Ling N, Shimasaki S 1995 The heparin-binding site of follistatin is involved in its interaction with activin. Biochem Biophys Res Commun 208:1-9
26. Hashimoto O, Nakamura T, Shoji H, Shimasaki S, Hayashi Y, Sugino H 1997 A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. J Biol Chem 272:13835-13842
27. Wang QF, Khoury RH, Smith PC, McConnell DS, Padmanahban V, Midgley AR, Schneyer AL, Crowley WF, Sluss PM 1996 A two-site monoclonal antibody immunoradiometric assay for human follistatin: secretion by a human ovarian teratocarcinoma-derived cell line (PA-1). J Clin Endocrinol Metab 81:1434-1441
28. McConnell DS, Wang QF, Sluss PM, Bolf N, Khoury RH, Schneyer AL, Midgley AR, Reame NE, Crowley WF, Padmanabhan V 1998 A two-site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state. J Clin Endocrinol Metab 83:851-858
29. Scott RS, Burger HG, Quigg H 1980 A simple and rapid in vitro bioassay for inhibin. Endocrinology 107:1536-1542
30. Cardin AD, Weintraub HJ 1989 Molecular modeling of protein- glycosaminoglycan interactions. Arteriosclerosis 9:21-32
31. Liu S, Zhou F, Hook M, Carson DD 1997 A heparin-binding synthetic peptide of heparin/heparan sulfate-interacting protein modulates blood coagulation activities. Proc Natl Acad Sci USA 94:1739-1744
32. Wong P, Burgess WH 1998 FGF2-heparin co-crystal complex-assisted design of mutants FGF1 and FGF7 with predictable heparin affinities. J Biol Chem 273:18617-18622
33. Huntington JA, Olson ST, Fan B, Gettins PG 1996 Mechanism of heparin activation of antithrombin: evidence for reactive centerloop preinsertion with expulsion upon heparin binding. Biochemistry 35:8495-8503
34. Hashimoto O, Kawasaki N, Tsuchida K, Shimasaki S, Hayakawa T, Sugino H 2000 Difference between follistatin isoforms in the inhibition of activin signalling: activin neutralizing activity of follistatin isoforms is dependent on their affinity for activin. Cell Signal 12:565-571
35. Schneyer A, Schoen A, Quigg A, Sidis Y 2003 Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG). Endocrinology 144:1671-1674
36. Wang QF, Keutmann HT, Schneyer AL, Sluss PM 2000 Analysis of human follistatin structure: identification of two discontinuous N-terminal sequences coding for activin A binding and structural consequences of activin binding to native proteins. Endocrinology 141:3183-3193
37. Yamane Y, Tohno-oka R, Yamada S, Furuya S, Shiokawa K, Hirabayashi Y, Sugino H, Sugahara K 1998 Molecular characterization of Xenopus embryo heparan sulfate. J Biol Chem 273:7375-7381
38. Shimonaka M, Inouye S, Shimasaki S, Ling N 1991 Follistatin binds to both activin and inhibin through the common β subunit. Endocrinology 128:3313-3315
39. Tortoriello DV, Sidis Y, Holtzman DA, Holmes WE, Schneyer AL 2001 Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. Endocrinology 142:3426-3434